LORIA, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.825
EU - Europa 7.447
AS - Asia 3.538
SA - Sud America 234
AF - Africa 29
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 8
Totale 29.096
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.778
GB - Regno Unito 2.804
SG - Singapore 1.147
IT - Italia 1.093
CN - Cina 987
SE - Svezia 938
DE - Germania 817
HK - Hong Kong 718
UA - Ucraina 539
TR - Turchia 460
RU - Federazione Russa 364
FI - Finlandia 309
BG - Bulgaria 207
BR - Brasile 189
FR - Francia 177
IN - India 49
NL - Olanda 41
BE - Belgio 30
ID - Indonesia 25
CA - Canada 24
MY - Malesia 21
ES - Italia 20
IE - Irlanda 17
JP - Giappone 17
BD - Bangladesh 16
CZ - Repubblica Ceca 16
LT - Lituania 16
TW - Taiwan 16
AR - Argentina 15
IR - Iran 14
MX - Messico 12
KR - Corea 11
RO - Romania 11
AT - Austria 10
CL - Cile 9
IQ - Iraq 9
AU - Australia 8
CH - Svizzera 8
EC - Ecuador 7
EU - Europa 7
NZ - Nuova Zelanda 7
MA - Marocco 6
SI - Slovenia 6
VN - Vietnam 6
ET - Etiopia 5
UZ - Uzbekistan 5
VE - Venezuela 5
CO - Colombia 4
CR - Costa Rica 4
EG - Egitto 4
GE - Georgia 4
HU - Ungheria 4
PH - Filippine 4
UG - Uganda 4
AZ - Azerbaigian 3
BO - Bolivia 3
CY - Cipro 3
GR - Grecia 3
RS - Serbia 3
ZA - Sudafrica 3
AL - Albania 2
BY - Bielorussia 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
PK - Pakistan 2
PL - Polonia 2
QA - Qatar 2
TH - Thailandia 2
TJ - Tagikistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BF - Burkina Faso 1
DZ - Algeria 1
GA - Gabon 1
GT - Guatemala 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
LV - Lettonia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
Totale 29.096
Salva come PNG Salva come JPEG
Città #
Fairfield 2.189
Southend 2.017
Santa Clara 1.907
Woodbridge 1.601
Houston 1.276
Jacksonville 1.218
Chandler 1.197
Ashburn 1.184
Seattle 834
Dearborn 796
Ann Arbor 776
Wilmington 761
Cambridge 720
Hong Kong 713
Singapore 654
Nyköping 546
Beijing 306
Modena 305
London 291
Izmir 284
San Diego 235
Princeton 220
Sofia 207
Eugene 201
Des Moines 166
New York 143
Moscow 122
Helsinki 112
Grafing 101
Council Bluffs 87
Falls Church 86
Shanghai 78
Bremen 58
Milan 52
Rome 47
Munich 44
Boardman 42
Redwood City 39
Kunming 38
Norwalk 35
San Mateo 33
Fremont 31
Hefei 31
Bologna 28
Brussels 27
Guangzhou 27
Jakarta 25
Kilburn 23
Jinan 19
Nanjing 19
Verona 19
Bari 18
Hounslow 18
São Paulo 18
Dongguan 17
Frankfurt am Main 17
Dublin 15
Brno 14
Chiswick 14
Nanchang 14
Toronto 14
Parma 13
Chicago 11
Los Angeles 11
Indiana 10
Phoenix 10
Shenyang 10
Taipei 10
Auburn Hills 9
Augusta 9
Dallas 9
Florence 9
Fuzhou 9
Madrid 9
North Salt Lake 9
Palermo 9
San Francisco 9
Washington 9
Amsterdam 8
Formia 8
Genova 8
Islington 8
Istanbul 8
Leawood 8
Mountain View 8
Nuremberg 8
Saint Petersburg 8
Baotou 7
Chengdu 7
Rio de Janeiro 7
Turin 7
Auckland 6
Chongqing 6
Dhaka 6
Monmouth Junction 6
Monza 6
Naples 6
Napoli 6
Prescot 6
Rio Saliceto 6
Totale 22.448
Salva come PNG Salva come JPEG
Nome #
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 334
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 285
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 260
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 245
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 245
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 242
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 235
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 234
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 230
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 223
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 222
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 221
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 219
Gender, fatty liver and GGT 215
Nonalcoholic fatty liver disease and aging: epidemiology to management 214
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 212
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis. 210
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 210
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 206
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 200
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 200
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 199
Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD) 199
Treatment of atherogenic liver based on the pathogenesis of nonalcoholic Fatty liver disease: a novel approach to reduce cardiovascular risk? 198
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 197
Risk factors for hospital readmission of elderly patients 196
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 193
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 193
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 191
Liver and kidney foreign bodies granulomatosis in a patient with malocclusion, bruxism, and worn dental prostheses 191
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 190
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD 188
Review article: diabetes, genetics and ethnicity 186
Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms. 186
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project) 184
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 181
Advances in the comprehension of the pathophysiology of bile secretion 180
Clinical physiology of NAFLD: A critical overview of pathogenesis and treatment 180
Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis 179
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 179
Endocrine and liver interaction: the role of endocrine pathways in NASH 179
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 178
From NAFLD in clinical practice to answers from guidelines. 177
Multiecho MR sequences and high-resolution magic angle spinning (HRMAS)ex-vivo spectroscopy in the qualitative analysis and differentiationbetween steatohepatitis and steatosis 176
Cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size 175
The hepatitis C virus-associated dysmetabolic syndrome. 175
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. 173
Review article: hepatic steatosis and insulin resistance 173
Effects of acute changes of bile acid pool composition on biliary lipid secretion 172
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 172
Chicken or egg turned into head or belly 171
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 171
Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. 169
Statins and HCV: a complex issue 167
Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease -Atherosclerosis As a Major Player in the Natural Course of NAFLD. 167
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 166
Apolipoprotein synthesis in nonalcoholic steatohepatitis 166
NAFLD and cardiovascular risk: direct evidence for the tale of two ages. 166
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question 165
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 165
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 165
Nonalcoholic fatty liver disease in HIV-infected persons: epidemiology and the role of nucleoside reverse transcriptase inhibitors. 165
Determinants of bile secretion: effect of bile salt structure on bile flow and biliary cation secretion 165
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. 164
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 164
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 164
'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis 163
Progetto MICOL - Multicentrica Italiana Colelitiasi 163
Of liver, whisky and plants: A requiem for colchicine in alcoholic cirrhosis? 161
Relationship of serum fetuin-a levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography. 161
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. 160
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 159
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 159
The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption. 157
Fisiologia della secrezione biliare. 157
Anatomia e fisiologia delle vie biliari 157
Nonalcoholic fatty liver disease induced by leuprorelin acetate 157
Growth hormone plasma levels in nonalcoholic fatty liver disease 156
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 155
Nonalcoholic fatty liver disease activity score and Brunt's pathologic criteria for the diagnosis of nonalcoholic steatohepatitis: what do they mean and do they agree? 155
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 155
MR techniques in the qualitative analysis of liver steatosis: the potential in the differentiation between steatohepatatis and steatosis 154
Metabolic alterations and chronic hepatitis C: treatment strategies. 154
Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B. 154
Bile acid structure and regulation of biliary protein secretion and composition in man 153
Liver and diabetes. A vicious circle 153
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 152
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. 152
Effect of ursocholic acid on bile lipid secretion and composition 151
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 151
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 150
RISK FOR CARDIOVASCULAR EVENTS IN AN ITALIAN POPULATION OF PATIENTS WITH TYPE 2 DIABETES 150
Dysmetabolic changes associated with HCV: a distinct syndrome? 150
Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid 149
Influence of age and sex on serum concentrations of total dimeric activin A 149
Diet and gallstones in Italy: the cross-sectional MICOL results. 149
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 149
Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies? 148
The prediction of coronary heart disease mortality as a function of major risk factors in over 30.000 men in the italian RIFLE Pooling Project. A comparison with the MRFIT primary screenees 147
Hepatitis C and diabetes: the inevitable coincidence? 147
Totale 18.099
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.973
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.218 0 0 0 0 0 0 0 0 474 172 332 240
2020/20213.733 363 139 324 320 391 294 369 545 133 452 257 146
2021/20223.583 51 502 394 313 87 156 261 204 392 213 607 403
2022/20233.279 363 354 205 326 401 583 72 310 385 29 142 109
2023/20242.003 84 119 114 136 457 221 216 286 56 42 75 197
2024/20254.831 263 87 129 495 1.607 971 588 413 278 0 0 0
Totale 29.248